Preview

Кардиоваскулярная терапия и профилактика

Расширенный поиск

Требования национальных кардиологических журналов Европейского общества кардиологов в отношении раскрытия конфликта интересов

Полный текст:

Аннотация

Раскрытие потенциального (возможного) конфликта интересов (КИ) в биомедицинских журналах призвано обеспечить надежность и прозрачность научного процесса. Тем не менее, большинство журналов не уделяют должного внимания систематическому, последовательному решению проблемы раскрытия КИ. В последние годы, благодаря совместным усилиям редакторов биомедицинских журналов, были разработаны единые механизмы уведомления о КИ. В настоящей статье подробно изложена точка зрения редакторов биомедицинских журналов на проблему КИ. Кроме того, представлены результаты выполненного с помощью стандартизованного вопросника исследования, которое оценивало существующие требования в отношении раскрытия КИ и их практическое внедрение в национальных кардиологических журналах Европейского общества кардиологов.

Об авторах

Ф. Альфонсо
Европейское общество кардиологов
Испания

MD PhD FESC

Chairman Editors’ Network

Interventional Cardiology. Cardiovascular Institute. Clinico San Carlos University Hospital. Plaza de Cristo Rey. Ciudad Universitaria. Madrid. Spain.
Tel: +34 91 549 4082, Fax: +34 91 330 3289



А. Тиммис
Европейское общество кардиологов
Великобритания

MD PhD FESC;

Editor-in-Chief, Heart



Ф. Дж. Пинто
Европейское общество кардиологов
Португалия

MD PhD FESC

Editor-in-Chief, Revista Portuguesa de Cardiologia



Дж. Амброзио
Европейское общество кардиологов
Италия

MD PhD FESC

Nucleus Member Editors’ Network



К. Эктор
Европейское общество кардиологов
Бельгия

MD PhD FESC

Editor-in-Chief, Acta Cardiologica



П. Кулаковски
Европейское общество кардиологов
Польша

MD PhD FESC

Editor-in-Chief, Kardiologia Polska



П. Вардас
Европейское общество кардиологов
Греция

MD PhD FESC

Editor-in-Chief, Hellenic Journal of Cardiology



Список литературы

1. International Committee of Medical Journals Editors. Uniform Requirements for Manuscript Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. (Updated October 2008). Available: http://www. icmje.org/.

2. Council of Science Editors. CSE´s White Paper on Promoting Integrity in Scientific Journal Publications. Editorial policy committee (2005–2006). Available: http://www.CouncilScienceEditors.org

3. World Association of Medical Editors. WAME recommendations on Publication Ethics and Policies for Medical Journals. Available: http://www.wame.org/resources/ethics-resources.

4. Committee On Publication Ethics. COPE. Code of Conduct and Best Practice Guidelines for Journal Editors. Available: http://publicationethics.org/resources/guidelines.

5. Alfonso F, Bermejo J, Segovia J. New recommendations of the international committee of medical journal editors. Shifting focus: from uniformity in technical requirements to bioethical considerations. Rev Esp Cardiol. 2004 Jun; 57 (6):592–3.

6. Blum JA, Freeman K, Dart RC, Cooper RJ. Requirements and definitions in conflict of interest policies of medical journals. JAMA 2009; 302 (20):2230–4.

7. Cooper RJ, Gupta M, Wilkes MS, Hoffman JR. Conflict of Interest Disclosure Policies and Practices in Peer-reviewed Biomedical Journals. J Gen Intern Med. 2006; 21 (12):1248–52.

8. Bekelman JE, MPhil YL, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003; 289 (4):454–65.

9. DeAngelis CD, Fontanarosa PB. Resolving unreported conflicts of interest. JAMA 2009; 302 (2):198–9.

10. Studdert DM, Mello MM, Phil M., Brennan TA. Financial conflicts of interest in physicians´relationships with the pharmaceutical industry. Self-regulation in the shadow of federal prosecution. N Engl J Med 2004; 351:1891–900.

11. Drazen JM, Van der Weyden MB, Sahni P, Rosenberg J, Marusic A, Laine C, Kotzin S, Horton R, Hébert PC, Haug C, Godlee F, Frizelle FA, de Leeuw PW, DeAngelis CD. Uniform format for disclosure of competing interests in ICMJE journals. N Engl J Med. 2009; 361 (19):1896–7.

12. Drazen JM, de Leeuw PW, Laine C, Mulrow C, DeAngelis CD, Frizelle FA, Godlee F, Haug C, Hébert PC, James A, Kotzin S, Marusic A, Reyes H, Rosenberg J, Sahni P, Van der Weyden MB, Zhaori G. Toward more uniform conflict disclosures – The updated ICMJE conflict of interest reporting form. N Engl J Med. 2010; 363 (2):188–9.

13. Alfonso F, Ambrosio G, Pinto FJ, Van der Wall EE, Kondili A, Nibouche D, Adamyan K, Huber K, Ector H, Masic I, Tarnovska R, Ivanusa M, Stanĕk V, Videbaek J, Hamed M, Laucevicius A, Mustonen P, Artigou JY, Cohen A, Rogava M, Böhm M, Fleck E, Heusch G, Klawki R, Vardas P, Stefanadis C, Tenczer J, Chiariello M, Elias J, Benjelloun H, Rødevand O, Kułakowski P, Apetrei E, Lusov VA, Oganov RG, Obradovic V, Kamensky G, Kenda MF, Höglund C, Lüscher TF, Lerch R, Jokhadar M, Haouala H, Sansoy V, Shumakov V, Timmis A. European National Society cardiovascular journals. Background, rationale and mission statement of the “Editors’ Club”. Rev Esp Cardiol. 2008 Jun; 61 (6):644–50.

14. Alfonso F, Ambrosio G, Pinto FJ, Ector H, Vardas P, Kulakowski P, Timmis A; Editors’ Network ESC Task Force. European Society of Cardiology national cardiovascular journals: the ‘Editors’ Network’. Eur Heart J. 2010 Jan; 31 (1):26–8.

15. Mills P, Timmis A, Huber K, Ector H, Lancellotti P, Masic I, Ivanusa M, Antoniades L, Aschermann M, Laucevicius A, Mustonen P, Artigou JY, Vardas P, Stefanadis C, Chiarello M, Bolognese L, Ambrosio G, van der Wall EE, Kułakowski P, Pinto FJ, Apetrei E, Oganov RG, Kamensky G, Lüscher TF, Lerch R, Haouala H, Sansoy V, Shumakov V, Tajer CD, Lau CP, Márquez M, Krittayaphong R, Arai K, Alfonso F. The role of European national journals in education. Heart. 2009 Dec; 95 (24): e3.

16. Alfonso F. The Editors’ Network of the European Society of Cardiology. Eur Heart J. 2011 Apr; 32 (8):919–21.

17. Schwartz RS, Curfman GD, Morrissey S, Drazen JM. Full disclosure and the funding of biomedical research. N Engl J Med 2008; 358 (17):1850–1.

18. Simone J. More interest in conflicts of interest. Lancet Oncol. 2009; 10:836–7.

19. Conti RC. Conflict of interest. Clin Cardiol 2009; 32:666–7

20. Fontanarosa PB, Flanagin A, DeAngelis CD. Reporting conflicts of interest, financial aspects of research and role of sponsors in funded studies. JAMA 2005; 294 (1):110–1.

21. Alpert JS. Doctors and the drug industry: how can we handle potential conflicts of interest? Am J Med. 2005 Feb; 118 (2):99–100.

22. Alpert JS. Doctors and the drug-industry: Further thoughts for dealing with potential conflicts of interest? Am J Med 2008 Apr; 121 (4):253–5.

23. Lanier WL. Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity? Mayo Clin Proc. 2009 Sep; 84 (9):771–5.

24. Bove A. Relations with industry: thoughts on claims of a broken system. J Am Coll Cardiol 2009; 54 (2):177–9.

25. Bodenheimer T. The uneasy alliance: Clinical investigators and the pharmaceutical industry. N Engl J Med 2000; 342 (20):1539–44.

26. Goldacre B. Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? Yes. BMJ. 2009 Nov 27; 339: b4949.

27. Davidoff F, de Angelis CD, Drazen JM, Hoey J, Hjgaard L, Horton R,, Kotzin S, Nicholls MG, Nylenna M, Overbeke JP, Sox HC, van der Weyden MB, Wilkes MS; International Committee of Medical Journal Editorset al. Sponsorship, authorship and accountability. Lancet. 2001; 358:854–6.

28. Johns MM, Barners M, Florencio PS. Restoring balance to industry-academia relationships in an era of institutional financial conflicts of interest: promoting research while maintaining trust. JAMA. 2003; 289 (6):741–6.

29. Alfonso F, Segovia J, Heras M, Bermejo J. Publication of clinical trials in scientific journals: Editorial issues. Rev Esp Cardiol. 2006 Nov; 59 (11):1206–14.

30. Patsopoulos NA, Analatos AA, Ioannidis JP. Origin and funding of the most frequently cited papers in medicine: database analysis. BMJ. 2006; 332 (7549):1061–4.

31. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003; 326 (7400):1167–70.

32. Finucane TE, Boult CE. Association of funding and findings of pharmaceutical research at a meeting of a medical professional society. Am J Med. 2004; 117 (11):842–5.

33. Hirsch LJ. Conflicts of interest, authorship, and disclosures in industry-related scientific publications: The tort bar and editorial oversight of medical journals. Mayo Clin Proc 2009; 84 (9):811–21.

34. Krzyanowska MK, Pintilie M, Tannock IF. Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA. 2003; 290 (4):495–501.

35. Chan AW, Krleza-JerićK, Schmid I, Altman DC. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ. 2004; 171 (7):735–40.

36. Alfonso F, Bermejo J, Segovia J. Duplicate or redundant publication: can we afford it?. Rev Esp Cardiol. 2005 May; 58 (5):601–4.

37. Hirsch L. Randomized clinical trials: what gets published, and when? CMAJ. 2004; 170 (4):481–3.

38. Kjaergard LL, Als-Nielsen B. Association between competing interests and authors’ conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ. 2002; 325 (7358):249

39. Ridker PM, Torres J. Reported outcomes in major cardiovascular clinical trials funded by for profit and not-for-profit organizations: 2000–2005. JAMA. 2006; 295 (19):2270–4.

40. Krimsky S, Rothenberg LS. Conflict of interest policies in science and medical journals: editors practices and authors disclosures. Sci Eng Ethics 2001; 7 (2):205–18.

41. Ancker JS, Flanagin A. A comparison of conflict of interest policies at peer-reviewed journals in different scientific disciplines. Sci Eng Ethics 2007; 13 (2):147–57.

42. Weinfurt KP, Seils DM, Tzeng JP, Lin L, Schulman KA, Califf RM. Consistency of financial interest disclosures in the biomedical literature: The case of coronary stents. PLoS ONE 2008; 3 (5): e2128.

43. Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med 2005; 2 (5): e138.

44. The Editors. Publishing commentary by authors with potential conflicts of interest: When, Why and How. Annals Intern Med 2004; 141 (1):73–4.

45. Vorobiof G. Do conflict of interest really matter or does no one read the fine print anyway? J Am Coll Cardiol 2008; 51 (19):1911.

46. Tanne JH. US Senate committee investigates conflicts of interest in industry funded medical education. BMJ. 2009 Aug 4; 339: b3139.

47. Rothman KJ. Conflict of interest. The new McCarthyism in science. JAMA 1993; 269 (21):2782–4.

48. Avanzas P, Bayes-Genis A, Pérez de Isla L, Sanchis J, Heras M. Ethical considerations in the publication of scientific articles. Rev Esp Cardiol. 2011 May; 64 (5):427–9.

49. ESC Statement on COI policy. European Heart Journal doi:10.1093/eurheartj/ehr464


Для цитирования:


Альфонсо Ф., Тиммис А., Пинто Ф.Д., Амброзио Д., Эктор К., Кулаковски П., Вардас П. Требования национальных кардиологических журналов Европейского общества кардиологов в отношении раскрытия конфликта интересов. Кардиоваскулярная терапия и профилактика. 2012;11(2):4-12.

For citation:


Alfonso F., Timmis A., Pinto F.J., Ambrosio G., Ector H., Kulakowski P., Vardas P. Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals. Cardiovascular Therapy and Prevention. 2012;11(2):4-12. (In Russ.)

Просмотров: 23


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1728-8800 (Print)
ISSN 2619-0125 (Online)